Clinical trials of add-on medications in Parkinson's disease: Efficacy versus usefulness
Open Access
- 31 January 1997
- journal article
- editorial
- Published by Elsevier BV in Parkinsonism & Related Disorders
- Vol. 3 (1), 1-6
- https://doi.org/10.1016/s1353-8020(96)00042-9
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Comparative study of selegiline plus L‐dopa–carbidopa versus L‐dopa–carbidopa alone in the treatment of parkinson's diseaseAnnals of Neurology, 1995
- A multicenter double‐blind placebo‐controlled trial of pergolide as an adjunct to sinemet® in Parkinson's diseaseMovement Disorders, 1994
- Early combination therapy (bromocriptine and levodopa) does not prevent motor fluctuations in Parkinson's diseaseNeurology, 1993
- Early combination therapy with bromocriptine and levodopa in parkinson's diseaseMovement Disorders, 1993
- Selegiline and levodopa in early or moderately advanced Parkinson's disease: a double-blind controlled short- and long-term studyActa Neurologica Scandinavica, 1989
- Early dopamine agonist therapy in Parkinson's diseaseMovement Disorders, 1989
- Early combination of bromocriptine and levodopa in the treatment of Parkinson's diseaseNeurology, 1987
- Combined bromocriptine‐levodopa therapy early in Parkinson's diseaseNeurology, 1985
- Double‐blind trial of pergolide for Parkinson's diseaseNeurology, 1985
- A Double–Blind Trial of Bromocriptine in Parkinson's DiseaseThe Medical Journal of Australia, 1978